Clinical Trial Update: Long-term Cardiovascular Risk Following Successful Renal Transplantation

View source ↗

Summary

A completed clinical trial studying long-term cardiovascular risk after successful renal transplantation. The sponsor is Helse Stavanger HF.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• End-stage Renal Disease

Snippet

Sponsor: Helse Stavanger HF | Conditions: Renal Transplant | Status: COMPLETED